{"url_path":"/sec/zeox/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-006486-index.html","accession_number":"0001829126-26-006486","cik":"0001557376","ticker":"ZEOX","issuer_name":"Zeo ScientifiX, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-006486-index.html","primary_entity_key":"0001557376","primary_entity_name":"Zeo ScientifiX, Inc."},"word_count":204,"has_tables":true,"body_markdown":"**Item 2.**\n**Unregistered Sales of Equity Securities and Use of Proceeds**\n\n \n\nOn November 1, 2025, pursuant to a subscription agreement (“Subscription Agreement”) with a single accredited investor (the “Investor”), the Investor purchased 25,000 shares for a purchase price of $100,000.\n\n \n\nFrom November 2025 to April 2026, the Company sold 7.4 Units to fifteen investors for an aggregate purchase price of $1,850,000 in a private transaction.\n\n \n\nDuring May 2026 and June 2026, the Company sold 0.8 Units to two investors in a private offering commenced in November 2025 (“Private Offering”), for an aggregate purchase price of $200,000. Each Unit sold in the Private Offering consists of (i) 62,500 shares of common stock and (ii) warrants to purchase 62,500 shares of common stock of the Company at an exercise price of $4.00 until November 30, 2030. The warrants may be exercised on a cashless basis. In connection with the sale of the Units, the Company issued 50,000 shares of common stock and 50,000 warrants to purchase shares of common stock.\n\n \n\nThe above securities were offered and sold to the investors in accordance with the exemption from registration afforded by Section 4(a)(2) of and/or Rule 506(b) of Regulation D under the Securities Act of 1933, as amended."}